Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18561908 | 1.00 | SIGMAR1 (0.36) | SIGMAR1PDK2KIF11L3MBTL1MCL1 | |
| SCHEMBL389968 | 1.00 | SIGMAR1 (0.36) | SIGMAR1PDK2KIF11L3MBTL1MCL1 | |
| SCHEMBL29363463 | 1.00 | SIGMAR1 (0.36) | SIGMAR1PDK2KIF11L3MBTL1MCL1 | |
| SCHEMBL29352224 | 1.00 | SIGMAR1 (0.36) | SIGMAR1PDK2KIF11L3MBTL1MCL1 | |
| SCHEMBL23597863 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2KIF11 | |
| SCHEMBL12560225 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2KIF11L3MBTL1 | |
| SCHEMBL19165668 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2KIF11L3MBTL1 | |
| SCHEMBL19165443 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2KIF11L3MBTL1 | |
| SCHEMBL25563171 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2KIF11L3MBTL1 | |
| SCHEMBL12640120 | 0.99 | SIGMAR1 (0.35) | SIGMAR1PDK2KIF11L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11594684-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-02-28 | — | — | US | disclosed |
| US-20210098700-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-01 | — | — | US | disclosed |
| WO-2013122364-A2 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE THEREWITH | 덕산하이메탈(주) (KR) | 2013-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11594684-B2 | Condensed-cyclic compound and organic light emitting device including the same | CRY1, SMCHD1, CXCR1 | SIGMAR1 1167/4885PDK2 2438/4885KIF11 1486/4885 |
| US-20210098700-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, SMCHD1, CXCR1 | SIGMAR1 1167/4885PDK2 2438/4885KIF11 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.